Dr. Basavaraj H

Introduction

Expertise

• Dr. Basavaraj's expertise lies in clinical radiation oncology and advanced technology conventional planning and delivering radiation therapy through various techniques, such as 3DCRT, IMRT/IGRT, RapidArc, SRS and SBRT.          
• He also has hands-on experience in advanced brachytherapy procedures – intracavitary brachytherapy (ICBT) /interstitial brachytherapy (ISBT) and intraluminal brachytherapy for cancers of esophagus, head and neck region, sarcoma and gynaecological malignancies, namely cervical and endometrial cancers.
• Dr. Basavaraj has handled over 3500 cases so far.

Recognition

• Dr. Basavaraj has attended numerous events where he has presented his papers and posters and bagged multiple awards:
  • Presented a poster “Incidence of Vaginal Adhesion in Patients Treated with Radical Radiotherapy in Carcinoma Cervix” December 2013 held in Goa -GOKARNA.
  • Presented a paper “Incidence of Laryngeal Edema in Head and Neck Cancer Patient Treated with Concurrent Chemoradiation.” AROICON Delhi-2013
  • Carcinoma oesophagus with Clivus metastasis Case series. HCG Oncology Mirror April 2017
  • Incidence of primary hypothyroidism in patients exposed to therapeutic external beam radiation, where radiation portals include a part or whole of the thyroid gland (Free paper) AROICON Bangalore 2018
  • Presented a Paper “Prospective comparative analysis of Dysphagia in Standard IMRT vs.
  • Dysphagia Aspiration Related Structure Sparing IMRT in Head and Neck Cancer. ICC Bangalore
  • He is a member of numerous associations, such as the Indian Medical Association, Association of Radiation Oncologist of India, Indian College of Radiation Oncology and Indian Brachytherapy Society.
• He has served as an investigator and principal investigator for many clinical trials and below are a few:
  • Unresectable EGFR mutation-positive Non-Small Cell Lung Cancer (Stage III) whose disease has not progressed following definitive platinum-based chemoradiation therapy (LAURA) (Principal investigator – Ongoing 2018)
  • Efficacy and safety of Intas Denosumab in comparison with Xgeva in patients with solid tumours with bone metastasis (Co-Investigator)

Other Doctors